↓ Skip to main content

Cochrane Database of Systematic Reviews

Oxcarbazepine for neuropathic pain

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
facebook
2 Facebook pages
f1000
1 research highlight platform

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
39 Mendeley
citeulike
1 CiteULike
Title
Oxcarbazepine for neuropathic pain
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd007963.pub2
Pubmed ID
Authors

Muke Zhou, Ning Chen, Li He, Mi Yang, Cairong Zhu, Fengbo Wu

Abstract

Neuropathic pain is difficult to treat. Oxcarbazepine is an anticonvulsant drug closely related to carbamazepine and is reportedly better tolerated. Oxcarbazepine has been reported to be efficacious in the treatment of neuropathic pain.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 21%
Researcher 5 13%
Student > Doctoral Student 5 13%
Student > Bachelor 4 10%
Other 3 8%
Other 8 21%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 17 44%
Nursing and Health Professions 6 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Psychology 2 5%
Immunology and Microbiology 1 3%
Other 3 8%
Unknown 7 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2015.
All research outputs
#5,786,003
of 21,346,377 outputs
Outputs from Cochrane database of systematic reviews
#7,779
of 12,077 outputs
Outputs of similar age
#45,920
of 175,440 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 91 outputs
Altmetric has tracked 21,346,377 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,077 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.